Keyphrases
Systemic Lupus Erythematosus Patient
100%
Epstein-Barr Virus
100%
Cytomegalovirus
100%
Human Herpesvirus 6 (HHV-6)
100%
Healthy Controls
42%
Epstein-Barr Virus Early Antigen
42%
Cytomegalovirus Reactivation
28%
Early Antigen
28%
Disease Activity Score
14%
Patient-controlled
14%
Patient Cohort
14%
Epstein-Barr Virus Infections
14%
Plasma Samples
14%
Systemic Lupus Erythematosus
14%
Enzyme-linked Immunosorbent Assay (ELISA)
14%
Immunoglobulin M
14%
Antibody Level
14%
Humoral Response
14%
Hematology
14%
Lymphocyte Count
14%
Serology
14%
Cytomegalovirus Infection
14%
IgG Levels
14%
DNA Polymerase
14%
Immunosuppressive Medication
14%
Processivity Factor
14%
Epstein-Barr Virus Reactivation
14%
Lymphocyte Level
14%
Immunology and Microbiology
Monospecific Antibody
100%
Epstein Barr Virus
100%
Systemic Lupus Erythematosus
100%
Cytomegalovirus
100%
Human Herpesvirus 6
100%
Early Antigen
55%
Immunoglobulin A
33%
Immunoglobulin M
22%
Blood Plasma
11%
Viral Disease
11%
Enzyme-Linked Immunosorbent Assay
11%
Lymphocyte
11%
Humoral Immunity
11%
Serology
11%
Immunosuppressive Drug
11%
Cytomegalovirus Infection
11%
DNA Polymerase
11%
Lymphocyte Count
11%